Texas lawsuit against companies behind Tylenol asserts unproven claims of autism risk

28.10.2025    WTOP    1 views
Texas lawsuit against companies behind Tylenol asserts unproven claims of autism risk

Texas Attorney General Ken Paxton on Tuesday accused the companies behind Tylenol of deceptively marketing the pain reliever to pregnant mothers in a lawsuit that asserted unproven alleges that early exposure to acetaminophen increased threat of autism and other disorders Paxton an ally of President Donald Trump and a Republican candidate for U S Senate released the suit against Johnson Johnson and Kenvue weeks after Trump and Robustness Secretary Robert F Kennedy Jr asserted an unproven link between the pain reliever and autism while announcing a wide-ranging effort to inquiry the causes of the complex brain disorder The suit alleges that the companies violated Texas consumer protection laws by hiding the danger that acetaminophen the functioning ingredient in Tylenol posed to fetuses and young children and deceptively marketed Tylenol as the only safe painkiller for pregnant women It also alleges that Johnson Johnson fraudulently transferred liabilities arising from Tylenol to Kenvue to shield assets against lawsuits In New Brunswick New Jersey-based J J reported that it would turn its consumer strength business which makes Tylenol and other products into a separate company now known as Kenvue It referenced that divestment in a comment Tuesday saying all rights and liabilities associated with the sale of its over-the-counter products including Tylenol acetaminophen are owned by Kenvue Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks These corporations lied for decades knowingly endangering millions to line their pockets Paxton disclosed in a comment Additionally seeing that the day of reckoning was coming Johnson Johnson attempted to escape responsibility by illegally offloading their liability onto a different company Acetaminophen has long been one of the the greater part popular pain relievers and fever reducers in the U S used by upward of million Americans annually Various studies have raised the possibility that taking Tylenol in pregnancy might be associated with a liability of autism but multiple others haven t unveiled a connection Kenvue stressed in a report Tuesday that acetaminophen is the safest pain reliever option for pregnant women noting that high fevers and pain are recognized as anticipated risks to pregnancies if left untreated The Summit New Jersey-based company stated it would defend itself against the contends and expressed concern about the perpetuation of misinformation about acetaminophen s safety and the promising impact on the physical condition of women and children We stand firmly with the global biological population that acknowledges the safety of acetaminophen and believe we will continue to be triumphant in litigation as these contends lack legal merit and scientific backing Kenvue disclosed Kenvue has mentioned it faces litigation in federal court over the autism insists noting earlier this year in an annual filing that numerous of those insists have been dismissed but are being appealed Source

Similar News

“There’s a cost”: Maddow blasts Comcast for donating to Trump’s White House ballroom
“There’s a cost”: Maddow blasts Comcast for donating to Trump’s White House ballroom

Rachel Maddow opened her Monday night show with a rebuke of her bosses’ bosses. The MSNBC host slamm...

28.10.2025 0
Read More
Serie A leader Napoli beats Lecce 1-0, Camarda in
Serie A leader Napoli beats Lecce 1-0, Camarda in tears after missed penalty

MILAN (AP) — Despite mounting injury problems, Napoli moved clear at the top of Serie A with a 1-0 w...

28.10.2025 0
Read More
Lindsey Vonn says she has ‘nothing to prove’ as she prepares to return to the Olympics
Lindsey Vonn says she has ‘nothing to prove’ as she prepares to return to the Olympics

NEW YORK — Lindsey Vonn feels like she has “nothing to prove” in her bid to return to the Olympics a...

28.10.2025 0
Read More